Evaluation strategies for measuring pneumococcal conjugate vaccine impact in low-resource settings-Reference-Cited by-同舟云学术

Evaluation strategies for measuring pneumococcal conjugate vaccine impact in low-resource settings

Published:2021-08-19 Issue: Volume: Page:1-9
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

von Mollendorf Claire¹²,Lim Ruth¹,Choummanivong Molina³,Sychareun Vanphanom³^ORCID,Vilivong Keoudomphone⁴,Lai Jana Y. R.¹,Chan Jocelyn¹,Dunne Eileen M.¹²,Phommachanh Sysavanh⁵,Moore Kerryn A.¹,Ortika Belinda D.¹,Gray Amy²,Weaver Rupert²,Mayxay Mayfong³⁴⁶,Phetsouvanh Rattanaphone⁴⁶,Datta Siddhartha S.⁷,Fox Kimberley⁸,Newton Paul N.⁴⁶⁹,Mulholland Kim E.¹²⁹,Nguyen Cattram D.¹²,Dance David A. B.⁴⁶⁹,Satzke Catherine¹²¹⁰,Russell Fiona M.¹²^ORCID

Affiliation:

1. Infection And Immunity, Murdoch Children’s Research Institute, The Royal Children’s Hospital, Melbourne, Australia

2. Department Of Paediatrics, The University of Melbourne, Melbourne, Australia

3. Faculty of Public Health, University Of Health Sciences, Ministry of Health, Vientiane, Lao PDR

4. Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR

5. Institute of Research and Education Development (IRED), University of Health Sciences, Ministry of Health, Vientiane, Lao PDR

6. Centre For Tropical Medicine And Global Health, University Of Oxford, Oxford UK

7. Division of Combating Communicable Disease, World Health Organization, Vientiane Lao PDR

8. Expanded Programme on Immunization, Regional Office for the Western Pacific, World Health Organization, Manila, Philippines

9. Faculty of Infectious & Tropical Diseases, London School Of Hygiene And Tropical Medicine, London, UK

10. Department Of Microbiology And Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia

Funder

Gavi

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1965474

Reference37 articles.

1. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15

2. International Vaccine Access Center JHUBSoPH. The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs): data for decision-making around PCV use in childhood. 2017 [cited 2019 Jul 15]. Available from: https://www.jhsph.edu/ivac/resources/the-evidence-base-for-pcvs/

3. Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project

4. World Health Organization. Measuring impact of Streptococcus pneumoniae and Haemophilus influenzae type b conjugate vaccination. 2012. [cited 202 Sep 14]. Available from:https://apps.who.int/iris/handle/10665/75835

5. GAVI The Vaccine Alliance. [cited 2020 Juk 15]. Available from: http://www.gavi.org/library/news/press-releases/2013/lao-first-south-east-asian-nation-to-introduce-pneumococcal-and-cervical-cancer-vaccines-with-gavi-support/

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pneumococcal serosurveillance: one piece of the puzzle;The Lancet Infectious Diseases;2023-11

2. Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People’s Democratic Republic;BMJ Global Health;2021-06